About IITRI
IITRI is a company based in United States founded in 1936 was acquired by Alion Science in December 2002. IITRI offers products and services including Toxicology Services, Biodefense Services, Inhalation Toxicology, and Immunology Services. IITRI operates in a competitive market with competitors including Advion, BioAgilytix, Tentamus, Alderley Analytical and Evans Analytical Group, among others.
- Headquarter United States
- SectorsHealthcare
- Phoneβ’β’β’β’ β’β’β’β’
- Website iitri.org
- Social LinkedIn X Facebook
- Acquired by Alion Science (Dec 2002)
- Legal Name Iit Research Institute
- Latest Funding Round$1.82M (USD), Grant
Dec 2010
- InvestorsHHS
& 1 more
- Acquired byAlion Science
(Dec 2002)
Products & Services of IITRI
IITRI offers a comprehensive portfolio of products and services, including Toxicology Services, Biodefense Services, Inhalation Toxicology, and Immunology Services.
Preclinical toxicology evaluation for drug safety and regulatory compliance.
Development of vaccines and therapeutics against pathogens.
Studies on inhaled drugs and aerosol challenges for safety.
Assays for immunogenicity and cellular responses in trials.
Funding Insights of IITRI
- Total Rounds 4
- Last Round Grant β $1.82M
- First Round $1.12M
(Jul 2007)
- Investors Count 1
All 4 funding rounds of IITRI with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in IITRI
IITRI has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Alion Science.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
Technology solutions are provided to U.S. federal government agencies. | 1936 | alionscience.com | Mclean, United States |
Investor details for IITRI
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of IITRI
12 people are tracked at IITRI (5 in leadership, 7 in team).
| Name | Role | Group |
|---|---|---|
Glenn Miller | Assistant Vice President And Manager | Leadership |
Todd Bucciarelli | Assistant VP & Director of Business Development | Leadership |
David L. McCormick | President | Leadership |
William D. Johnson | Assistant VP & Manager of Toxicology Division | Leadership |
Fannell Matthews | Assistant Vice President Of Administration And Manager Of Finance | Leadership |
Israr Ahmad | Senior Toxicologist | Team |
Larry N. | Project Financial Analyst | Team |
Mary Smeaton | HR Manager | Team |
Patti Paas | Senior Human Resources Associate | Team |
Landon Westfall | Division Manager Microbiology And Molecular Biology | Team |
Justin Mussman | Laboratory Biologist II | Team |
Sridhar Jaligama | Manager of Inhalation Toxicology | Team |
Complete people profiles for IITRI
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of IITRI
4 dated milestones of IITRI across 74 years, from founding to its latest funding, stage changes and deals.
- Founded IITRI is founded.
- Exit Acquired by Alion Science.
- Funding First funding round of $1.1M.
- Funding Latest funding round, Grant, of $1.8M.
Competitors of IITRI
IITRI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Advion, BioAgilytix, Tentamus, Alderley Analytical and Evans Analytical Group, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| advion.com | 1993 | Ithaca, United States | $45.64M | 54 | Microfluidics and mass spectrometry products are provided for clinical research. | |
| bioagilytix.com | 2008 | Durham, United States | – | 446 | Large-molecule bioanalysis is provided for biologics and biosimilars development. | |
| tentamus.com | 2011 | Berlin, Germany | – | 368 | Analytical and quality assurance services are provided for diverse industries. | |
| alderleyanalytical.com | 2013 | Stockport, United Kingdom | $869,352 | 41 | Bioanalytical assays for drug development are developed and validated. | |
| eag.com | 1978 | San Diego, United States | – | 601 | Company offering a suite of scientific services for materials, engineering, agri, and life science industries | |
| apocell.com | 2004 | Houston, United States | – | 2,198 | Provider of clinical trial and clinical development on bioanalytical services | |
| nordicbioscience.com | 1996 | Herlev, Denmark | – | 178 | Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform | |
| nuvisan.com | 1979 | Neu Ulm, Germany | – | 1,011 | Clinical trial supply and bioanalytical services are provided globally. | |
| lightcast.bio | 2019 | Cambridge, United Kingdom | $107.09M | 25 | Advanced single-cell analysis solutions are provided for biotechnology research. | |
| immunxperts.com | 2014 | Charleroi, Belgium | $1M | 22 | Human immune system-based bioassays are developed for drug applications. |
Detailed competitors of IITRI
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of IITRI
The website of IITRI (iitri.org) receives about 2.4K visits a month.
- Monthly visits2.4K
▼ 38% vs previous month
Similar companies to IITRI
10 companies that operate in the same segment as IITRI (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about IITRI
IITRI was founded in 1936 and raised its 1st funding round 71 years after it was founded.
IITRI is headquartered in United States.
The company was founded in 1936 in the United States as a provider of bioanalytical services. Operations are centered in the biotechnology sector, where analytical testing and data support are delivered to clients in pharmaceuticals and life sciences. Services encompass bioanalytical methods for drug discovery and validation, conducted through established laboratory facilities. The domain iitri.org serves as the primary online platform for information and outreach.
IITRI's top competitors include Alderley Analytical, BioAgilytix and Lightcast Discovery.
IITRI offers Toxicology Services, Biodefense Services, Inhalation Toxicology, and Immunology Services.
IITRI has 2 investors. Key investors include HHS, and Alion Science.
IITRI operates through Iit Research Institute.
Yes. IITRI was acquired by Alion Science in December 2002.
